Oncotype DX vs Delfi Diagnostics

Side-by-side comparison of cancer screening tests.

← Back to Cancer Screening

Oncotype DX

Guideline recommended
Variable

Breast recurrence risk

Delfi Diagnostics

Not FDA approved
Variable

Lung cancer

Test Performance

FeatureOncotype DXDelfi Diagnostics
PriceVariableVariable
Cancers DetectedBreast recurrence riskLung cancer
SensitivityN/A80% sensitivity
SpecificityN/A58% specificity
Sample TypeTumor tissueBlood draw
FDA StatusGuideline recommendedNot FDA approved